SEC Comment Letter for Mystic Holdings (MSTH) — Sep 15, 2021

Mystic Holdings Inc./NV (MSTH) (CIK 0001790320)
Date: Sept. 15, 2021 · CIK: 0001790320 · Accession: 0000000000-21-011191

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 024-11631

Date

September 15, 2021

Author

Lorenzo Barracco

Form

UPLOAD

Company

Mystic Holdings Inc./NV (MSTH) (CIK 0001790320)

Letter

United States securities and exchange commission logo September 15, 2021 Lorenzo Barracco Chief Executive Officer Mystic Holdings, Inc. 4145 Wagon Trail Avenue Las Vegas, NV 89118 Re:Mystic Holdings, Inc. Offering Statement on Form 1-A Filed September 9, 2021 File No. 024-11631 Dear Mr. Barracco: This is to advise you that we do not intend to review your offering statement. We will consider qualifying your offering statement at your request. If a participant in your offering is required to clear its compensation arrangements with FINRA, please have FINRA advise us that it has no objections to the compensation arrangements prior to qualification. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. We also remind you that, following qualification of your Form 1-A, Rule 257 of Regulation A requires you to file periodic and current reports, including a Form 1-K which will be due within 120 calendar days after the end of the fiscal year covered by the report. Please contact Ada D. Sarmento at 202-551-3798 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Spencer G. Feldman, Esq.

Show Raw Text

United States securities and exchange commission logo
September 15, 2021
Lorenzo Barracco
Chief Executive Officer
Mystic Holdings, Inc.
4145 Wagon Trail Avenue
Las Vegas, NV 89118
Re:Mystic Holdings, Inc.
Offering Statement on Form 1-A
Filed September 9, 2021
File No. 024-11631
Dear Mr. Barracco:
            This is to advise you that we do not intend to review your offering statement.
            We will consider qualifying your offering statement at your request. If a participant in
your offering is required to clear its compensation arrangements with FINRA, please have
FINRA advise us that it has no objections to the compensation arrangements prior to
qualification.
            We remind you that the company and its management are responsible for the accuracy
and adequacy of their disclosures, notwithstanding any review, comments, action or absence of
action by the staff. We also remind you that, following qualification of your Form 1-A, Rule 257
of Regulation A requires you to file periodic and current reports, including a Form 1-K which
will be due within 120 calendar days after the end of the fiscal year covered by the report.
            Please contact Ada D. Sarmento at 202-551-3798 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc:       Spencer G. Feldman, Esq.

SecProbe.io